Assignee
POSEIDA THERAPEUTICS INC
US·22 granted patents·44 pending applications·107 citations·filing 2013–2025
Top patents by PatentIndex Score
66 records- 0196US10513686B2Modified stem cell memory T cells, methods of making and methods of using samePOSEIDA THERAPEUTICS INC·Filed 2018·Granted Dec 24, 2019·12 cites·30 claims
- 0295US10329543B2Modified stem cell memory T cells, methods of making and methods of using samePOSEIDA THERAPEUTICS INC·Filed 2017·Granted Jun 25, 2019·14 cites·28 claims
- 0395US10131885B2Hyperactive piggybac transposasesPOSEIDA THERAPEUTICS INC·Filed 2017·Granted Nov 20, 2018·11 cites·17 claims
- 0494US10287559B2Hyperactive PiggyBac transposasesPOSEIDA THERAPEUTICS INC·Filed 2016·Granted May 14, 2019·7 cites·17 claims
- 0593US11718656B2Inducible caspases and methods for usePOSEIDA THERAPEUTICS INC·Filed 2022·Granted Aug 8, 2023·1 cites·10 claims
- 0692US10415024B2Site-specific enzymes and methods of usePOSEIDA THERAPEUTICS INC·Filed 2013·Granted Sep 17, 2019·25 cites·8 claims
- 0792US9546382B2Hyperactive piggybac transposasesPOSEIDA THERAPEUTICS INC·Filed 2013·Granted Jan 17, 2017·12 cites·24 claims
- 0890US10456452B2Compositions and methods for improved encapsulation of functional proteins in polymeric vesiclesPOSEIDA THERAPEUTICS INC·Filed 2016·Granted Oct 29, 2019·15 cites·11 claims
- 0989US10415016B2Modified stem cell memory T cells, methods of making and methods of using samePOSEIDA THERAPEUTICS INC·Filed 2018·Granted Sep 17, 2019·3 cites·22 claims
- 1086US12358966B2Inducible caspases and methods for usePOSEIDA THERAPEUTICS INC·Filed 2023·Granted Jul 15, 2025·0 cites·7 claims
- 1186US11802269B2Superpiggybac transposase compositionsPOSEIDA THERAPEUTICS INC·Filed 2019·Granted Oct 31, 2023·1 cites·5 claims
- 1286US11377480B2Inducible caspases and methods for usePOSEIDA THERAPEUTICS INC·Filed 2017·Granted Jul 5, 2022·2 cites·1 claims
- 1381US11485959B2Hyperactive piggybac transposasesPOSEIDA THERAPEUTICS INC·Filed 2019·Granted Nov 1, 2022·1 cites·16 claims
- 1480US12415844B2BCMA specific VCAR compositions and methods for usePOSEIDA THERAPEUTICS INC·Filed 2018·Granted Sep 16, 2025·1 cites·79 claims
- 1580US2026001929A1Inducible caspases and methods for usePOSEIDA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1678US10844361B2Site-specific enzymes and methods of usePOSEIDA THERAPEUTICS INC·Filed 2019·Granted Nov 24, 2020·1 cites·17 claims
- 1778US2024150734A1Hyperactive piggybac transposasesPOSEIDA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1877US10131634B2Method of treating painPOSEIDA THERAPEUTICS INC·Filed 2014·Granted Nov 20, 2018·1 cites·2 claims
- 1976US2024318136A1Modified stem cell memory t cells, methods of making and methods of using samePOSEIDA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2074US2024084251A1Modified stem cell memory t cells, methods of making and methods of using samePOSEIDA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2171US2024226153A9Compositions and methods for selective elimination and replacement of hematopoietic stem cellsPOSEIDA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2265US2026071213A1Compositions targeting hbg1 and hbg2 and methods of use thereofPOSEIDA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2365US2020338361A1Compositions and methods for inducing nanoparticle-mediated microvascular embolization for tumorsPOSEIDA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2464US2025171809A1Genetically modified cells and methods of use thereofPOSEIDA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2563US2021062170A1Site-specific enzymes and methods of usePOSEIDA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2663US2026021207A1Super minimal inverted terminal repeat (itr) sequences and uses thereofPOSEIDA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2763US2026022354A1Transposases and uses thereofPOSEIDA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2863US2026022353A1Transposase polynucleotides and uses thereofPOSEIDA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2963US2026055383A1Transposases and uses thereofPOSEIDA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3063US2023257737A1Compositions and methods for directing proteins to specific loci in the genomePOSEIDA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3163US2019119636A1Modified stem cell memory t cells, methods of making and methods of using samePOSEIDA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3263US2026085332A1Chimeric transposases and uses thereofPOSEIDA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3362US11744861B2Compositions and methods for selective elimination and replacement of hematopoietic stem cellsPOSEIDA THERAPEUTICS INC·Filed 2018·Granted Sep 5, 2023·0 cites·19 claims
- 3462US10987409B2Compositions and methods for improved encapsulation of functional proteins in polymeric vesiclesPOSEIDA THERAPEUTICS INC·Filed 2019·Granted Apr 27, 2021·0 cites·10 claims
- 3562US2024401085A1Transposon compositions and methods of use thereofPOSEIDA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3662US2020138716A1Compositions and methods for inducing nanoparticle-mediated microvascular embolization of tumorsPOSEIDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3762US2025099383A1Compositions and methods for delivery of nucleic acidsPOSEIDA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3861US2024392262A1Transposase and uses thereofPOSEIDA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3960US2026069539A1Lipidoid compounds and related compositions and usesPOSEIDA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4060US2026083860A1Compositions and methods for genome editingPOSEIDA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4159US2024060090A1Genetically modified induced pluripotent stem cells and methods of use thereofPOSEIDA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4258US2026069714A1Lipidoid compounds and related compositions and usesPOSEIDA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4357US2024182921A1Compositions and methods for the treatment of hemophiliaPOSEIDA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4456US2019135759A1Method of treating painPOSEIDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4555US2022042038A1Nanotransposon compositions and methods of usePOSEIDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4655US2020001110A1Compositions and methods for inducing nanoparticle-mediated microvascular embolization for tumorsPOSEIDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4755US2019233843A1Transposon system and methods of usePOSEIDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4855US2026042732A1Sulfur-containing Compounds and Compositions Thereof for Delivery of Nucleic AcidsPOSEIDA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4954US2023079955A1Anti-muc1 compositions and methods of usePOSEIDA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 5053US2024189446A1Compositions and methods for delivery of nucleic acidsPOSEIDA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Showing the top 50 of 66 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when POSEIDA THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →